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Background: Accurate staging is critical for decision-making for the treatment of malignant conditions.
Fluoro-deoxy-glucose positron emission tomography-computed tomography (FDG PET-CT) is a highly sensitive imaging
modality for the assessment of distant metastases; however false positive results are possible due to its lower specificity
with detection of other hypermetabolic pathologies.
Case presentation: A patient with high-risk thigh melanoma was staged with FDG PET-CT. Four ipsilateral inguinal nodes
(three superficial, one deep) demonstrated intense hypermetabolic activity. Metastatic melanoma was confirmed in the
largest superficial inguinal node with ultrasound-guided fine needle aspiration. Histopathology demonstrated metastatic
melanoma in one superficial node and histiocytic necrotizing lymphadenitis, also known as Kikuchi-Fujimoto disease in
five deep inguinal nodes.
Conclusion: This case illustrates a false positive FDG PET-CT due to coincidental, synchronous melanoma and
Kikuchi-Fujimoto disease in the same draining lymph node basin.
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Kikuchi-Fujimoto disease (KFD) is a rare, benign condition
of unknown etiology that mostly affects young women. It
typically manifests as cervical lymphadenopathy and un-
commonly as widespread lymphadenopathy, and is associ-
ated with constitutional symptoms of fever, malaise, and
weight loss. Affected lymph nodes may display increased
avidity on fluoro-deoxy-glucose positron emission tomog-
raphy (FDG PET) and on histopathology show a mitotically
active lymphoid infiltrate with necrosis, sometimes leading
to a misdiagnosis of malignancy [1]. Here, we describe a
woman with melanoma of the leg with FDG-avid superficial
and deep inguinal lymph nodes, found to be due to concur-
rent metastatic melanoma and KFD.* Correspondence: Greg.Mckinnon@albertahealthservices.ca
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A 37 year old Caucasian woman presented to our refer-
ral centre with invasive melanoma. For one year she
had noticed a posterior thigh raised pigmented lesion,
which rapidly grew over three months. It measured
2 cm and bled spontaneously. She had no constitutional
symptoms such as fever, malaise, or weight loss, or
significant medical history. Histopathology of the initial
shave biopsy demonstrated invasive melanoma with
Breslow thickness greater than 4.9 mm (positive deep
margin), Clark level IV, ulceration, and a mitotic rate of
28 mitoses per square millimeter.
Physical examination revealed a 2.5 cm healing biopsy
site on the left thigh with residual pigmentation. Further
examination was unremarkable, with no satellite lesions,
in-transit disease, palpable lymphadenopathy or abdom-
inal organomegaly. No additional suspicious skin lesions
were identified.
Due to the aggressive pathological features of the pri-
mary lesion and difficulty with clinical nodal assessment
due to the patient’s body habitus, she was staged withral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the ipsilateral left superficial inguinal lymph node basin,
the largest of which measured 19 x 14 mm, and two or
three adjacent tiny lymph nodes. Additionally, a single
9 mm deep inguinal (external iliac) lymph node demon-
strated intense hypermetabolic activity (Figure 1A and B).
Moderate hypermetabolic activity was seen on the poster-
ior left thigh corresponding to the residual neoplasm and
biopsy site. There was some physiological FDG uptake but
no further suspicious areas identified. Ultrasound-guided
fine-needle aspiration of the largest superficial left inguinal
lymph node demonstrated metastatic melanoma.
The patient underwent a wide local excision of the
primary tumor and left superficial and deep inguinal
node dissection.
Pathology identified eleven lymph nodes in the superficial
and deep lymphadenectomy specimen. One of the superfi-
cial left inguinal lymph nodes contained metastatic melan-
oma, confirmed by HMB-45 and melan-A positivity.
However, five deep inguinal lymph nodes (2 large and 3
smaller nodes) were partially involved by a florid atypical
lymphohistiocytic proliferation with a brisk mitotic rate
and abundant necrosis. The specimen was referred for
Hematopathology consultation due to a concern of high-
grade lymphoma. The involved lymph nodes showed partialFigure 1 FDG PET and CT images (A) Axial FDG PET and CT images demons
body FDG PET demonstrating intense avidity in three inguinal superficial lymp
(red arrow). Hypermetabolism is seen in the left thigh biopsy site and likely ph
CT images demonstrating the avid left deep inguinal lymph node.architectural effacement by a mixed proliferation of small
lymphocytes, large immunoblast-like lymphocytes, and his-
tiocytes, present in a predominantly paracortical distribu-
tion. Mitotic rate in these areas was very brisk (up to 10
mitoses per high power field). Many of the histiocytes had
eccentric crescent-shaped nuclei and contained abundant
intracytoplasmic karyorrhectic debris (Figure 2A). Neutro-
phils and eosinophils were noticeably absent. In some areas,
the cellular proliferation was entirely replaced by large
zones of necrosis. Fibrin thrombi were identified within nu-
merous blood vessels in and around the necrotic areas. By
immunohistochemistry, most of the lymphocytes were CD8
positive cytotoxic T-cells. The abundant histiocytes were
highlighted by CD68 (Figure 2B) and lysozyme, and also
showed strong expression of myeloperoxidase (Figure 2C).
Ki-67 staining confirmed a high proliferative index of ap-
proximately 80% (Figure 2D). The uninvolved areas of the
lymph node showed reactive follicular hyperplasia and fine
septal fibrosis, but were otherwise normal. These morpho-
logic and immunophenotypic features are classic for
histiocytic necrotizing lymphadenitis, also known as KFD.
This proliferation was morphologically and immuno-
phenotypically distinct from the patient’s concurrent metastatic
melanoma, which consisted of sheets of large, pleomorphic
epithelioid cells with expression of HMB-45 and melan-A.trating intense avidity in a left superficial inguinal lymph node; (B) Whole
h nodes (black arrow) and left deep inguinal (external iliac) lymph node
ysiologic changes in the right and left adnexae. (C) Axial FDG PET and
Figure 2 Kikuchi-Fujimoto disease histopathology A Sheet-like lymphohistiocytic infiltrate with crescentic histiocytes and abundant karyorrhectic
debris (hematoxylin-eosin, 400x magnification). B Histiocytes are highlighted by CD68 (400x magnification). C Histiocytes co-express myeloperoxidase
(400x magnification). D High proliferative index is highlighted by Ki-67 (400x magnification).
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KFD is a poorly understood and rare condition which most
commonly affects young women of Asian descent, but also
males and children. The true incidence of KFD is difficult
to ascertain due to its heterogeneous, often subtle symp-
toms. KFD typically presents as tender cervical lymphaden-
opathy, but may involve other lymph node regions and
rarely presents as generalized lymphadenopathy. While it
is often otherwise asymptomatic, KFD may also exhibit a
constellation of non-specific symptoms including fever,
upper respiratory tract symptoms, weight loss, night sweats,
fatigue, nausea and vomiting [1]. Uncommonly there may
be cutaneous manifestations such as rash, macules or
papules, or ulcers [2]. KFD usually develops over two to
three weeks and spontaneously resolves after a few months.
Treatment is generally supportive care only but severe
cases may require non-steroidal anti-inflammatories or
corticosteroids. Hydroxychloroquine, methotrexate,
and intravenous immunoglobulin have also been used
for severe cases [2]. KFD may relapse and exceptionally
rare cases have resulted in death [3].
Imaging findings are usually non-specific, and KFD may
be mistaken for lymphoma, other malignancies, tubercu-
losis lymphadenitis, or Kawasaki disease [1]. The number,
size (usually <4 cm) and location (neck most common) of
involved lymph nodes can be useful for suggesting the
diagnosis [4]. Because of the brisk proliferation rate, lymphnodes involved by KFD are hypermetabolic on FDG PET-
CT. The maximum standard uptake values (SUVmax)
of FDG uptake can be used to differentiate benign and
malignant tumors, but in a series of seven patients with
KFD, the SUVmax ranged from 2.05-13.94 (mean +/−SD,
6.25+/−3.32), which is similar to malignancies [4]. In that
study, lymph node size weakly correlated with SUVmax,
but the authors suggested that the FDG uptake was more
dependent on the number of macrophages and neutrophils
in the lymph node tissue [4]. The diagnosis is most reliably
made by histopathologic examination of an excised affected
lymph node.
The etiology of KFD remains highly speculative. The
clinical symptoms and pathological findings suggest a viral
cause but no specific agent has been identified. It has been
proposed that an infectious process initiates a self-limited
autoimmune response. However, reports have been con-
flicting, with some implicating viruses such as Epstein-Barr
virus, human herpes virus 6, 7, 8 and parvovirus B19, but
others refuting them [5,6]. It is still possible that KFD
develops after eradication of these viruses, or that other
viruses contribute to the pathology [6]. KFD has also
been associated with autoimmune conditions, in particular
systemic lupus erythematosus (SLE). The association is
not well defined, and it is unclear if SLE can present with
lymphadenopathy with similar pathological features of
KFD or if KFD may be an early manifestation of SLE.
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recommend following KFD patients clinically for SLE [2].
To our knowledge, there are no other reported cases of a
simultaneous diagnosis of melanoma and KFD. Melanoma is
susceptible to immune modulation. Although there has been
an association noted between SLE and melanoma, a large
Danish population-based study found that the incidence of
melanoma was not increased in those with autoimmune
diseases [7,8]. In our patient, the only FDG-avid lympha-
denopathy was in the regional lymph node basin draining
the melanoma. It is unclear whether this was due to a
possible immunological association between melanoma and
KFD, whether there was a reaction from the biopsy of the pri-
mary site or if whether the co-existence is pure coincidence.
NCCN guidelines recommend staging with FDG PET or
CT for stage III and IV melanoma [9]. In this case, a FDG
PET-CT was requested because of the unusually aggressive
features of the primary tumor, as well as the patient’s body
habitus that made clinical examination of lymph nodes
difficult. Potential drawbacks in the use of FDG PET-CT or
CT for staging are the possibility of false positive results
that vary in incidence between 0-27%, which are more
common when staging nodal disease compared with vis-
ceral metastases [10].
In our patient, a superficial inguinal lymphadenectomy
was appropriately performed for fine-needle aspiration
proven metastatic melanoma. However, evidence of deep
lymph node involvement on FDG PET-CT also prompted a
deep inguinal lymphadenectomy. Without concomitant
KFD, only superficial nodal involvement would have been
identified on FDG PET-CT and a superficial inguinal lymph
node dissection would have been considered adequate.
Conclusions
In summary, we report a patient with synchronous meta-
static melanoma and KFD found during inguinal lymphad-
enectomy. This case highlights a possible association
between the two diseases and a potential pitfall of false-
positive FDG-PET imaging. FDG PET-CT findings initially
indicated hypermetabolic nodes in the superficial and deep
inguinal lymph nodes that were suspicious for metastatic
spread of melanoma given the patient’s clinical history. Al-
though melanoma was identified in the superficial nodes,
it was only after surgical removal and histological evalu-
ation that KFD was identified in the deep inguinal chains.
This case illustrates the importance of recognizing the
possible false positives found with FDG PET-CT due to
concurrent hypermetabolic pathology.
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